While for NSCLC, PD-L2 and CTLA-4 obtained relatively higher accuracy in Prat et al., 2017 (Figure 5D and Figure S25, AUC = 0.73 for PD-L2 and AUC = 0.72 for CTLA-4). This evidence concerns the gene PDCD1LG2 and non-small cell lung carcinoma.